Treatment of pediatric high‐grade central nervous system tumors with high‐dose methotrexate in combination with multiagent chemotherapy: A single‐institution experience-Reference-Cited by-同舟云学术

Treatment of pediatric high‐grade central nervous system tumors with high‐dose methotrexate in combination with multiagent chemotherapy: A single‐institution experience

Published:2019-12-18 Issue:3 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Bernstock Joshua D.¹²,Alva Elizabeth³,Cohen Joshua L.¹,Lobbous Mina⁴⁵,Chagoya Gustavo⁵,Elsayed Galal A.⁵^ORCID,Orr Brent A.⁶,Rozzelle Curtis⁵,Rocque Brandon⁵,Blount Jeffrey⁵,Johnston James M.⁵,Li Rong⁷,Fiveash John B.⁸,Dhall Girish³,Reddy Alyssa T.⁹,Friedman Gregory K.³⁵^ORCID

Affiliation:

1. Medical Scientist Training ProgramUniversity of Alabama at Birmingham Birmingham Alabama

2. Department of NeurosurgeryBrigham and Women'sHarvard Medical School Boston Massachusetts

3. Division of Pediatric Hematology and OncologyDepartment of PediatricsUniversity of Alabama at Birmingham Birmingham Alabama

4. Department of NeurologyUniversity of Alabama at Birmingham Birmingham Alabama

5. Department of NeurosurgeryUniversity of Alabama at Birmingham Birmingham Alabama

6. Pathology DepartmentSt. Jude Children's Research Hospital Memphis Tennessee

7. Department of PathologyChildren's of Alabama Birmingham Alabama

8. Department of Radiation OncologyUniversity of Alabama at Birmingham Birmingham Alabama

9. Department of NeurologyUniversity of California at San Francisco San Francisco California

Funder

Rally Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28119

Reference42 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

2. Change in Neurocognitive Functioning After Treatment With Cranial Radiation in Childhood

3. Pediatric Brain Tumors: An Update

4. Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group

5. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time;Cancers;2023-06-27

2. Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy;Pediatric Blood & Cancer;2023-04-18

3. Folate Antagonists;Holland‐Frei Cancer Medicine;2022-10-21

4. Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN ‐amplified neuroblastoma cells;Cancer Science;2020-06-10

5. Methotrexate;Reactions Weekly;2020-04